The ADC binds TROP-2 on tumor cells, is internalized, and releases a topoisomerase I–inhibiting payload that causes DNA damage and apoptosis. Topoisomerase I is the intracellular enzymatic target of the payload, not the directly targeted cell-surface antigen.